Vnitr Lek 2009, 55(10):976-980

Skin adverse effects of amiodarone

S. Zgažarová*, H. Jedličková, V. Vašků
I. dermatovenerologická klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MUDr. Vladimír Vašků, CSc.

Background:
Amiodarone has belonged to frequently used antiarrhythmic in the treatment of supraventricular and ventricular tachyarrhytmias since the sixties of the twentieth century. Amiodarone is a chemically iodinated benzofuran derivative with mono-N-desethylamiodarone as its major metabolite.

Objective: This review is focused on numerous adverse reactions. The incidence of amiodarone induced side-effects ranges from 16-98% of patients receiving amiodarone and it appears to be dose related.

Case reports: We describe three cases of hyperpigmentation after using amiodarone in elder men.

Conclusion: Skin side effects are common, they usually occur as photosensitivity, more rarely as a slate-grey discoloration of the skin. Amiodarone induced slate-grey pigmentation is commonly observed in unprotected light exposed skin. Its incidence ranges from 2-57%. Hyperpigmentation is due to accumulation of amiodarone and its metabolites in the skin.

Keywords: amiodarone; photosensitivity; hyperpigmentation; adverse effects

Received: January 26, 2009; Accepted: March 26, 2009; Published: October 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zgažarová S, Jedličková H, Vašků V. Skin adverse effects of amiodarone. Vnitr Lek. 2009;55(10):976-980.
Download citation

References

  1. Hrčková Y, Šarapatková H, Lukl J. Vedlejší účinky amiodaronu. Interní Med 2005; 6: 288-290.
  2. Jiravská Godula B, Jiravský O, Vávra P et al. Nežádoucí účinky amiodaronu. Klin Farmakol Farm 2004; 18: 171-174.
  3. Jafari-Fesharaki M, Scheinman MM. Adverse effects of amiodarone. Pacing Clin Electrophysiol 1998; 21: 108-120. Go to original source... Go to PubMed...
  4. Ammoury A, Michaud S, Paul C et al. Photodistribution of blue-gray hyperpigmentation after amiodarone treatment. Arch Dermatol 2008; 144: 92-96. Go to original source... Go to PubMed...
  5. Delage C, Lagacé R, Huard J. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can Med Assoc J 1975; 112: 1205-1208. Go to PubMed...
  6. Dissemond J, Franckson T, Fitz G et al. Hyperpigmentierung des Gesichts. Hautarzt 2003; 54: 994-998. Go to original source... Go to PubMed...
  7. Janota T, Malík J, Holaj R et al. Méně obvyklé nežádoucí účinky amiodaronu. Interní Med 2006; 11: 513-514.
  8. Lüllmann H, Mohr K, Wehling M. Farmakologie a toxikologie. 2. vyd. Praha: Grada 2004: 192-194.
  9. Shah N, Warnakulasuriya S. Amiodarone-induced peri-oral photosensitivity. J Oral Pathol Med 2004; 33: 56-58. Go to original source... Go to PubMed...
  10. Bahadir S, Apaydin R, Cobanoilu Ü et al. Amiodarone pigmentation, eye and thyroid alterations. J Eur Acad Dermatol Venereol 2000; 14: 194-195. Go to original source... Go to PubMed...
  11. Ettler K, Gregor J, Pidrman V et al. Skin side-effects of amiodarone therapy. Sb Ved Pr Lek Fak Karlovy University Hradec Králové 1993; 36: 305-315.
  12. Lee A, Thomson J. Drug-induced skin reactions. In: Lee A (ed). Adverse drug reactions. 2nd ed. London: Pharmaceutical Press 2006: 143-147.
  13. Li AS, Chignell CF. Spectroscopic studies of cutaneous photosensitizing agents-ix. A spin trapping study of the photolysis of amiodarone and desethylamiodarone. Photochem Photobiol 1987; 45: 191-197. Go to original source... Go to PubMed...
  14. Yones SS, O'Donoghue NB, Palmer RA et al. Persistent severe amiodarone-induced photosensitivity. Clin Exp Dermatol 2005; 30: 500-502. Go to original source... Go to PubMed...
  15. Boyer M, Katta R, Markus R. Diltiazem-induced photodistributed hyperpigmentation. Dermatol Online J 2003; 9: 10. Go to original source...
  16. Jhirwal OP, Parsad D, Basu D. Skin hyperpigmentation induced by olanzapine, a novel antipsychotic agent. Int J Dermatol 2004; 43: 778-779. Go to original source... Go to PubMed...
  17. Mansani FP, Dinis TC, Carnieri EG et al. Neutrality of amiodarone on the initiation and propagation of membrane lipid peroxidation. Cell Biochem Funct 1999; 17: 131-142. Go to original source... Go to PubMed...
  18. Ramírez-Hernández M, Martínez-Escribano JA, Martínez-Barba E et al. Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis. J Eur Acad Dermatol Venereol 2006; 20: 584-587. Go to original source... Go to PubMed...
  19. Ribeiro SM, Campello AP, Nascimento AJ et al. Effect of amiodarone (AMD) on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism. Cell Biochem Funct 1997; 15: 145-152. Go to original source... Go to PubMed...
  20. Trappe HJ. Amiodaron. Intensivmed 2001; 38: 169-178. Go to original source...
  21. Jung T, Bader N, Grune T. Lipofuscin: formation, distribution, and metabolic consequences. Ann NY Acad Sci 2007; 1119: 97-111. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.